Dare Bioscience, Inc. - COM (DARE)

Historical Portfolio Holders from Q3 2017 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
7.19M
Holdings value Q2 2024
$2.45M
Value change Q2 2024
+$42.9K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
24
Number of buys Q2 2024
13
Number of sells Q2 2024
-19
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 7.19M $2.45M +$42.9K $0.34 24
2024 Q1 6.82M $3.35M +$123K $0.49 34
2023 Q4 6.6M $2.04M -$2.97M $0.31 34
2023 Q3 12.9M $5.97M +$2.89M $0.46 30
2023 Q2 6.51M $5.92M -$381K $0.91 27
2023 Q1 6.89M $7.16M -$95K $1.04 29
2022 Q4 7.01M $5.82M -$388K $0.83 30
2022 Q3 7.29M $12.2M +$3.73M $1.00 29
2022 Q2 7.42M $9.12M +$870K $1.23 35
2022 Q1 6.64M $9.89M -$742K $1.49 38
2021 Q4 6.87M $13.7M +$4.9M $2.00 37
2021 Q3 4.83M $8.07M +$2.38M $1.67 33
2021 Q2 3.38M $6.39M -$377K $1.89 30
2021 Q1 3.6M $6.09M -$2.2M $1.69 25
2020 Q4 4.98M $6.66M +$3.7M $1.34 22
2020 Q3 2.22M $2.21M +$591K $1.00 17
2020 Q2 1.63M $1.61M +$651K $0.99 15
2020 Q1 932K $791K +$89.6K $0.85 17
2019 Q4 870K $713K +$59.3K $0.82 10
2019 Q3 803K $623K -$38.8K $0.77 14
2019 Q2 853K $725K -$4.97K $0.85 11
2019 Q1 789K $1.1M +$129K $1.40 13
2018 Q4 733K $519K -$132K $0.71 13
2018 Q3 863K $841K +$90.4K $0.97 14
2018 Q2 769K $899K -$146K $1.17 13
2018 Q1 1.03M $864K -$54.7K $0.84 11
2017 Q4 483K $1.04M -$36K $2.16 10
2017 Q3 491K $1.53M +$1.53M $3.12 10